We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

Company news from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

BASF-nominated Harbour Energy director exits as German firm cuts stake

Tue 09 June 2026 09:20

(Sharecast News) - BASF's representation on Harbour Energy's board has been reduced with removal of one of two of its nominated directors, as the German chemical giant continues to lower its position in the UK-listed oil explorer.

OpenAI files confidential paperwork for IPO

Tue 09 June 2026 09:00

(Sharecast News) - ChatGPT developer OpenAI announced on Monday that it has filed confidential paperwork for an initial public offering, paving the way for one of the most closely watched market debuts in years.

Oxford Instruments shares fall despite results ahead of expectations

Tue 09 June 2026 08:55

(Sharecast News) - Oxford Instruments shares fell more than 6% on Tuesday morning despite the company reporting full-year results slightly ahead of expectations, as investors focused on weaker revenue, lower adjusted profit and pressure in its Advanced Te

FRC to probe PwC's 2024 audit of WHSmith

Tue 09 June 2026 08:47

(Sharecast News) - The Financial Reporting Council opened an investigation into PwC's audit of WH Smith's accounts for the year ended 31 August 2024 on Tuesday, adding to regulatory scrutiny of the travel retailer after it disclosed inflated earnings in i

Keller secures $207m variation to I-40 contract

Tue 09 June 2026 08:10

(Sharecast News) - Geotechnical contractor Keller said on Tuesday that it has been awarded a contract variation order in relation to the reconstruction of the I-40 highway in the US.

GSK to buy Boston-based biopharma firm Nuvalent for $10.6bn

Tue 09 June 2026 07:38

(Sharecast News) - GSK said on Tuesday that it has agreed to buy Boston-based oncology-focused biopharmaceutical firm Nuvalent for $10.6bn (£7.9bn).

Bellway sees softer demand, rising building costs

Tue 09 June 2026 07:09

(Sharecast News) - UK housebuilder Bellway held guidance but said customer demand had moderated in recent weeks after a positive start to the spring selling season as geopolitical tensions pushed energy and fuel costs higher.

Molten Ventures reports sharp rise in profit, ICEYE valuation uplift

Tue 09 June 2026 07:00

(Sharecast News) - Molten Ventures reported a sharp rise in annual profit and net asset value on Tuesday, alongside a further valuation uplift from portfolio company ICEYE after the satellite intelligence business completed a major funding round.

Campbell's sales fall as Q3 results hit by tariff, inflation headwinds

Mon 08 June 2026 14:44

(Sharecast News) - Soup and snacks food manufacturer Campbell's reiterated its full-year guidance this fiscal year despite a dip in sales over its third quarter, as subdued demand outweighed higher prices.

AMD pledges to invest £2bn into UK AI innovation and research

Mon 08 June 2026 14:10

(Sharecast News) - American semiconductor giant AMD announced a commitment to invest £2bn in the UK over the next five years to accelerate AI innovation and research.